Research ExplorerPublicationsTherapy of necrobiotic xanthogranuloma - case series and rev...

Therapy of necrobiotic xanthogranuloma - case series and review of the literature

Standard

Therapy of necrobiotic xanthogranuloma - case series and review of the literature. / Hansen, Inga; Ghandili, Susanne; Abeck, Finn; Booken, Nina; Schneider, Stefan W.

In: J DTSCH DERMATOL GES, Vol. 21, No. 11, 11.2023, p. 1315-1318.

Research output: SCORING: Contribution to journal › Short publication › Research › peer-review

Harvard

Hansen, I, Ghandili, S, Abeck, F, Booken, N & Schneider, SW 2023, 'Therapy of necrobiotic xanthogranuloma - case series and review of the literature', J DTSCH DERMATOL GES, vol. 21, no. 11, pp. 1315-1318. https://doi.org/10.1111/ddg.15195

APA

Hansen, I., Ghandili, S., Abeck, F., Booken, N., & Schneider, S. W. (2023). Therapy of necrobiotic xanthogranuloma - case series and review of the literature. J DTSCH DERMATOL GES, 21(11), 1315-1318. https://doi.org/10.1111/ddg.15195

Vancouver

Hansen I, Ghandili S, Abeck F, Booken N, Schneider SW. Therapy of necrobiotic xanthogranuloma - case series and review of the literature. J DTSCH DERMATOL GES. 2023 Nov;21(11):1315-1318. https://doi.org/10.1111/ddg.15195

Bibtex

@article{11715d0dfa784a89974b0b82581ef455,
title = "Therapy of necrobiotic xanthogranuloma - case series and review of the literature",
abstract = "Necrobiotic xanthogranuloma is a rare disease that is part of the non-Langerhans cell histiocytoses. It is characterized by yellowish skin lesions, which are typically periorbitally localized. Extracutaneous manifestations of all organs are possible and can cause potentially life-threatening complications. The disease also belongs to the facultative paraneoplasias and is often associated with paraproteinemia. These aspects should be considered regarding further diagnostics. Due to the rarity of the disease, there are no standardized guidelines for therapy so far. The combination of prednisolone and chlorambucil as well as intravenous immunoglobulins seem to be effective therapeutic options. We present four cases from our clinic as well as the current results of the literature in this mini-review and would like to highlight the therapeutic challenge as well as the need for the development of guidelines.",
author = "Inga Hansen and Susanne Ghandili and Finn Abeck and Nina Booken and Schneider, {Stefan W}",
note = "{\textcopyright} 2023 The Authors. Journal der Deutschen Dermatologischen Gesellschaft published by John Wiley & Sons Ltd on behalf of Deutsche Dermatologische Gesellschaft.",
year = "2023",
month = nov,
doi = "10.1111/ddg.15195",
language = "English",
volume = "21",
pages = "1315--1318",
journal = "J DTSCH DERMATOL GES",
issn = "1610-0379",
publisher = "Wiley-Blackwell",
number = "11",

}

RIS

TY - JOUR

T1 - Therapy of necrobiotic xanthogranuloma - case series and review of the literature

AU - Hansen, Inga

AU - Ghandili, Susanne

AU - Abeck, Finn

AU - Booken, Nina

AU - Schneider, Stefan W

N1 - © 2023 The Authors. Journal der Deutschen Dermatologischen Gesellschaft published by John Wiley & Sons Ltd on behalf of Deutsche Dermatologische Gesellschaft.

PY - 2023/11

Y1 - 2023/11

N2 - Necrobiotic xanthogranuloma is a rare disease that is part of the non-Langerhans cell histiocytoses. It is characterized by yellowish skin lesions, which are typically periorbitally localized. Extracutaneous manifestations of all organs are possible and can cause potentially life-threatening complications. The disease also belongs to the facultative paraneoplasias and is often associated with paraproteinemia. These aspects should be considered regarding further diagnostics. Due to the rarity of the disease, there are no standardized guidelines for therapy so far. The combination of prednisolone and chlorambucil as well as intravenous immunoglobulins seem to be effective therapeutic options. We present four cases from our clinic as well as the current results of the literature in this mini-review and would like to highlight the therapeutic challenge as well as the need for the development of guidelines.

AB - Necrobiotic xanthogranuloma is a rare disease that is part of the non-Langerhans cell histiocytoses. It is characterized by yellowish skin lesions, which are typically periorbitally localized. Extracutaneous manifestations of all organs are possible and can cause potentially life-threatening complications. The disease also belongs to the facultative paraneoplasias and is often associated with paraproteinemia. These aspects should be considered regarding further diagnostics. Due to the rarity of the disease, there are no standardized guidelines for therapy so far. The combination of prednisolone and chlorambucil as well as intravenous immunoglobulins seem to be effective therapeutic options. We present four cases from our clinic as well as the current results of the literature in this mini-review and would like to highlight the therapeutic challenge as well as the need for the development of guidelines.

U2 - 10.1111/ddg.15195

DO - 10.1111/ddg.15195

M3 - Short publication

C2 - 37811744

VL - 21

SP - 1315

EP - 1318

JO - J DTSCH DERMATOL GES

JF - J DTSCH DERMATOL GES

SN - 1610-0379

IS - 11

ER -